Ftse Mib
34.603,61
-0,64%
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
70.217,44
0,12%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Predictive Oncology Inc (POAI) Predictive Oncology Inc (POAI) Notizie

POAI

Predictive Oncology (POAI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:POAI
DataOraFonteTitoloSimboloCompagnia
21/05/202421:39Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:POAIPredictive Oncology Inc
15/05/202413:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:POAIPredictive Oncology Inc
14/05/202423:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:POAIPredictive Oncology Inc
07/12/202314:54Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:POAIPredictive Oncology Inc
05/12/202322:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:POAIPredictive Oncology Inc
04/10/202323:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:POAIPredictive Oncology Inc
15/05/202323:15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:POAIPredictive Oncology Inc
13/05/202300:42Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:POAIPredictive Oncology Inc
02/05/202323:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:POAIPredictive Oncology Inc
18/04/202312:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:POAIPredictive Oncology Inc
18/04/202300:00GlobeNewswire Inc.Predictive Oncology Adjourns Special Meeting of StockholdersNASDAQ:POAIPredictive Oncology Inc
05/04/202319:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:POAIPredictive Oncology Inc
29/03/202323:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:POAIPredictive Oncology Inc
17/03/202322:11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:POAIPredictive Oncology Inc
16/03/202322:15GlobeNewswire Inc.Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common StockNASDAQ:POAIPredictive Oncology Inc
16/03/202322:11Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:POAIPredictive Oncology Inc
09/03/202314:30GlobeNewswire Inc.Predictive Oncology Issues Letter to ShareholdersNASDAQ:POAIPredictive Oncology Inc
28/02/202323:31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:POAIPredictive Oncology Inc
23/02/202314:30GlobeNewswire Inc.Predictive Oncology and Cvergenx announce partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligenceNASDAQ:POAIPredictive Oncology Inc
21/02/202314:30GlobeNewswire Inc.Predictive Oncology launches ACE program to partner with academic and research institutions to advance their drug discovery initiativesNASDAQ:POAIPredictive Oncology Inc
03/02/202314:31GlobeNewswire Inc.Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business OfficerNASDAQ:POAIPredictive Oncology Inc
12/01/202314:30GlobeNewswire Inc.Pioneer of Computational Biology Joins the Scientific Advisory Board of Predictive OncologyNASDAQ:POAIPredictive Oncology Inc
13/12/202214:30GlobeNewswire Inc.Distinguished Innovator in Genomics Joins the Scientific Advisory Board of Predictive OncologyNASDAQ:POAIPredictive Oncology Inc
05/12/202214:30GlobeNewswire Inc.Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of DirectorsNASDAQ:POAIPredictive Oncology Inc
10/11/202223:15GlobeNewswire Inc.Predictive Oncology Reports Third Quarter Financial ResultsNASDAQ:POAIPredictive Oncology Inc
25/10/202214:30GlobeNewswire Inc.David S. Smith appointed to the Board of Directors of Predictive OncologyNASDAQ:POAIPredictive Oncology Inc
20/10/202214:30GlobeNewswire Inc.Predictive Oncology Announces New Chief Executive Officer Raymond F. Vennare to Lead Company GrowthNASDAQ:POAIPredictive Oncology Inc
14/10/202212:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:POAIPredictive Oncology Inc
13/10/202223:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:POAIPredictive Oncology Inc
30/09/202223:07Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:POAIPredictive Oncology Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:POAI

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
G
Generali
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
TITR
Telecom Italia
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network